Amarin Corp PLC (AMRN) stock
AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3063% above fair value
$11.38−0.29 (-2.49%)
Close on Nov 13, 2026Market cap $251.55MP/E –Yield –
Amarin ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Amarin's ebitda for the twelve months ending Jun 30, 2019 was -$79.25M. For fiscal 2018 it was -$108.20M. The highest annual figure on record is -$33.46M in fiscal 2009.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | -$108.20M | – |
| FY2017 | Dec 31, 2017 | -$45.49M | – |
| FY2016 | Dec 31, 2016 | -$65.49M | – |
| FY2015 | Dec 31, 2015 | -$98.06M | – |
| FY2014 | Dec 31, 2014 | -$95.76M | – |
| FY2013 | Dec 31, 2013 | -$181.86M | – |
| FY2012 | Dec 31, 2012 | -$116.57M | – |
| FY2011 | Dec 31, 2011 | -$44.09M | – |
| FY2010 | Dec 31, 2010 | -$45.04M | – |
| FY2009 | Dec 31, 2009 | -$33.46M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2019 | Jun 30, 2019 | -$2.51M | – |
| Q1 FY2019 | Mar 31, 2019 | -$22.73M | – |
| Q4 FY2018 | Dec 31, 2018 | -$31.76M | – |
| Q3 FY2018 | Sep 30, 2018 | -$22.25M | – |
| Q2 FY2018 | Jun 30, 2018 | -$32.30M | – |
| Q1 FY2018 | Mar 31, 2018 | -$21.89M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.14M | – |
| Q3 FY2017 | Sep 30, 2017 | -$8.44M | – |
| Q2 FY2017 | Jun 30, 2017 | -$11.38M | – |
| Q1 FY2017 | Mar 31, 2017 | -$18.53M | – |
| Q4 FY2016 | Dec 31, 2016 | -$12.84M | – |
See a number that looks wrong?